Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...

Promoted by nutrition pros and research, the DASH diet is at the top of the diet charts. Learn why this is a smart eating plan and how it could benefit more than just your blood pressure.

Nearly half of Type 2 diabetes patients suffer from micronutrient deficiencies, with vitamin D and magnesium being the most ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

Medicine and Gonzaga University will host a panel featuring experts on diabetes to discuss new developments in glucose monitoring strategies.

Samsung might be the first to crack the non-invasive blood glucose monitoring code, but gaining FDA approval will be the ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

But what exactly is driving this sudden attention towards Trinity Biotech, and how does it compare to broader market trends? Let’s explore. Trinity Biotech is a commercial-stage biotechnology company ...

Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...

Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...